Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Novartis? half-billion dollar investment in a new biologics production plant in Singapore represents a strategic commitment to its growing biologics portfolio.

Novartis Making Moves to Increase Biologics Manufacturing Capability

Mylan completes expansion of its transdermal patch facility in Vermont.

Mylan Completes Expansion of Vermont Transdermal Patch Facility

Sanofi and POZEN sign a license agreement for the commercialization of omeprazole and aspirin combination product.

Sanofi and POZEN Sign Commercial Agreement for PA8140/PA32540 Tablets

Following passage in the California Assembly, the California State Senate passes legislation to specify requirements for dispensing biosimilars.

California State Senate Passes Biosimilars Bill

Merck & Co gets FDA approval to manufacture bulk varicella at its in Durham, North Carolina for use in chickenpox and shingles vaccines.

Merck & Co. Gets FDA Nod to Manufacture Bulk Vaccine at North Carolina Facility

Baxter and Coherus Biosciences colaborate to develop and commercialize a biosimilar version of etanercept for Europe, Canada, and, Brazil.

Baxter and Coherus Biosciences Collaborate On Biosimilars

Ronald A. Rader is senior director, Technical Research, at BioPlan Associates.

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

Bioprocessing Advances in Vaccine Manufacture

Prequalification of Sanofi Pasteur?s Menomune vaccine makes it eligible for purchase by United Nations agencies.

Sanofi Pasteur's Meningococcal Vaccine is Prequalified by the World Health Organization

Avacta?s Optim 2 instrument provides a practical solution for determining the conformational stability of adjuvant bound vaccines, eliminating the need for awkward and time consuming standard analytical techniques. [more?..]

MEASURING THE PHYSICAL STABILITY OF SUBUNIT VACCINES

Joanne Ratcliff, PhD, is communications project manager, Laboratory Weighing, Mettler Toledo GmbH, Joanne.Ratcliff@mt.com.

George Hartford is laboratory technician/inventory coordinator for labeled compounds in analytical chemistry, Merck Research Laboratories, 126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065-0900, USA.

Karen Whitaker is senior specialist, Rahway Safety and the Environment, Merck Research Laboratories, 126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065-0900, USA.

Patty Cheung is associate principle scientist in analytical chemistry, Merck Research Laboratories, 126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065-0900, USA.

Roy Helmy, PhD, is director of analytical chemistry, all at Merck Research Laboratories, 126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065-0900, USA.

The advantages of using an automated powder dispensing system in a ventilated balance enclosure for efficient handling and effective containment of potent compounds are discussed.